Novel Tacrine Analogs as Potential Cholinesterase Inhibitors in Alzheimer's Disease
作者:Afaf El-Malah、Ehab M. Gedawy、Asmaa E. Kassab、Rania M. Abdel Salam
DOI:10.1002/ardp.201300121
日期:2014.2
Acetylcholinesterase inhibitors (AChEIs) are used for the treatment of Alzheimer'sdisease (AD). The increase in ACh levels ameliorates the symptoms of the disease. Tacrine is the first clinically approved drug as AChEI used in the treatment of AD. In this paper, we synthesized new tacrineanalogs to act on catalytic and peripheral sites of AChE. Their inhibitory activity was evaluated. All novel compounds except
Bindra, Jasjit S.; Rastogi, Shri Nivas; Patnaik, G. K., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1987, vol. 26, p. 318 - 329
作者:Bindra, Jasjit S.、Rastogi, Shri Nivas、Patnaik, G. K.、Anand, N.、Rao, K. G. Gurudath、et al.